Login
Home / PRPO : NASDAQ
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Precipio, Inc.

$27.15 +$3.33 (+13.98%)
NASDAQ · 14 Sep 2026 14:36 UTC
Previous Close
$27.32
Day Range
$27$27.69
Year Range
$16$33.63
Market Cap
48.43M
AVG Volume
89.9K
Trailing/Forward PE
-41.48/0.99
PEG ratio
-0.62
Dividend Yield
-
Next Earnings Date
2026-11-16
Primary Exchange
NASDAQUS
Revenue (USD)
02M4M6M8M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (USD)
-3M-2M-1M01M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (USD)
-3M-2M-1M01M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (USD)
-2M-1M01M2M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (USD)
-1M-500K0500K1M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (USD)
-1.5-1-0.500.524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (USD)
-2M02M4M6MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (USD)
02M4M6M8MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-20-15-10-50524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-20%-15%-10%-5%0%5%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0500K1M1.5M2M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Book Value Per Share (USD)
02.557.51024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (USD)
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Employee Count
0204060802013201720182019202020212022202320242025
Free Cash Flow Yield
-15%-10%-5%0%5%10%med 1.46%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
00.511.522.5med 1.35Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
050100150200250med 106.27Nov 25Jan 26Feb 26Apr 26Jun 26Jul 26Sep 26
Price/Operating Cashflow
020406080med 43.53Jun 25Aug 25Nov 25Jan 26Apr 26Jun 26Sep 26
Price to Book
01234med 2.24Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Precipio, Inc.
PRPO
Stockpicker

Video analysis: PRPO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PRPO

PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?

zacks.com · 24 Aug 2026

PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?

Precipio and Biodesix take different approaches to cancer diagnostics, but which stock looks more compelling now? Let's dive in.
Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong

zacks.com · 21 Aug 2026

Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong

PRPO's second-quarter 2026 revenue momentum strengthens on higher diagnostic volumes and record product sales, alongside positive adjusted EBITDA and cash generation.
Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript

seekingalpha.com · 17 Aug 2026

Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript

Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript
Precipio Announces Q2-2026 Financial Results

globenewswire.com · 14 Aug 2026

Precipio Announces Q2-2026 Financial Results

Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cash position Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cash position
Precipio (NASDAQ:PRPO) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell?

defenseworld.net · 1 Aug 2026

Precipio (NASDAQ:PRPO) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell?

Precipio, Inc. (NASDAQ: PRPO - Get Free Report) passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $25.12 and traded as low as $20.20. Precipio shares last traded at $21.65, with a volume of 21,130 shares trading hands. Analysts Set New Price Targets A number of
Precipio Announces Q2-2026 Shareholder Update Call

globenewswire.com · 31 Jul 2026

Precipio Announces Q2-2026 Shareholder Update Call

NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q2-2026 shareholder update call on August 17th, 2026, at 5:00 PM ET.
PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?

zacks.com · 16 Jul 2026

PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?

Precipio and NeoGenomics take different approaches to cancer diagnostics, but which oncology stock looks more compelling now? Let's dive in.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.